Brief: Avidity Partners Management Reports 9.7% Passive Stake In Fusion Pharmaceuticals As Of Oct 18- SEC Filing
23/10/2023 22:56
Oct 23 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* AVIDITY PARTNERS MANAGEMENT LP REPORTS 9.7% PASSIVE STAKE
IN
FUSION PHARMACEUTICALS, INC. AS OF OCTOBER 18- SEC FILING
Further company coverage: FUSN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary